Navigation Links
Whistleblower Kickback Case Against Alpharma Results In $42.5 Million Recovery for U.S. and States
Date:3/17/2010

WASHINGTON, March 17 /PRNewswire/ -- Alpharma Inc. has agreed to pay $42.5 million to the federal government and certain states to settle a whistleblower lawsuit that exposed an alleged kickback scheme by the pharmaceutical company to boost its sales of Kadian, a prescription painkiller.

"Patients need to know their doctors are prescribing drugs solely because it will benefit them – not the doctor's bank account," said Mary Louise Cohen, a Washington, DC, attorney with Phillips & Cohen LLP, which represents the whistleblower.

The settlement was announced Tuesday by the U.S. Department of Justice, which had joined the "qui tam" (whistleblower) case. The government investigation was led by Assistant U.S. Attorneys Jamie Bennett and Thomas Corcoran in Baltimore and Senior Trial Counsel Daniel Spiro in the Justice Department's Washington headquarters.

The qui tam lawsuit alleged that Alpharma was paying kickbacks to doctors to encourage them to prescribe Kadian, a morphine-based drug, for both federally approved uses and "off-label" uses that the U.S. Federal Drug Administration hadn't approved.

These inducements included payments for sham "consulting" arrangements, payments for attendance at meetings held at fancy resorts with lavish entertainment and also "educational grants," which were just thinly disguised kickbacks.

Federal anti-kickback laws prohibit drug manufacturers from offering inducements to physicians for the purpose of influencing the physicians' prescribing practices. The anti-kickback laws are designed to ensure that doctors prescribe medications based upon informed, impartial medical judgment unaffected by personal financial motivations.

Alpharma is now a wholly owned subsidiary of King Pharmaceuticals Inc., based in Bristol, Tennessee. The settlement will be split between the federal government ($33.6 million) and certain states that participated in the lawsuit ($8.9 million).

About Phillips & Cohen LLP

Phillips & Cohen LLP is the most successful law firm representing whistleblowers in the nation. "Qui tam" lawsuits brought by Phillips & Cohen have resulted in civil and criminal recoveries totaling $5.3 billion. Phillips & Cohen also represents whistleblowers in cases involving major tax violations and securities laws violations. The firm's attorneys are regularly recognized for their successful work on whistleblower cases with inclusion on such select lists as the Top 10 "Winning Attorneys" in the U.S., the "100 Most Influential Lawyers" and the National Law Journal's "Hot List" of plaintiffs' law firms. See www.phillipsandcohen.com.

SOURCE Phillips & Cohen LLP

Back to top

RELATED LINKS
http://www.phillipsandcohen.com

'/>"/>

SOURCE Phillips & Cohen LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfizer Whistleblower Named Years Most Influential Person In Business Ethics
2. Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies
3. U.S. Files Suit Against Johnson & Johnson For Paying Kickbacks to Nations Largest Nursing Home Pharmacy
4. Harborside Healthcare to Pay U.S. $1.375 Million to Resolve Allegations of Kickbacks and Sham Durable Medical Services
5. Atherotech Recruits Top Experts in Fight Against Heart Disease
6. Adamas Pharmaceuticals TCAD Therapy Demonstrates Broad Spectrum Activity Against Susceptible and Resistant Strains of Influenza in Animal Models
7. Jury Verdict Against Novartis Pharmaceuticals For Retaliating Against Drug Sales Rep Who Took Maternity Leave
8. Caliper Life Sciences and Stanford University File a Patent Infringement Lawsuit Against Carestream Health, Inc.
9. Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains
10. Date Set for LightLab Damages Trial Against Volcano and Axsun
11. Celsis Initiates Patent Infringement Action Against XenoTech and Sekisui
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
Breaking Medicine News(10 mins):